Market closed · After hours · 5:13 PM ET
Last update: Nov 17, 2026, 5:12 PM ET
Oscar Health, Inc.
$29.84▼ 4.76% today
After Hours

Why Oscar Health, Inc. (OSCR) stock moved

Latest session▼ 4.8% · Nov 17, 2026 close

Why Oscar Health, Inc. (OSCR) fell 4.8% today, November 17, 2026

Oscar Health, Inc. (OSCR) fell 4.8% on November 17, 2026, closing at $29.84 versus $31.33 the prior session (close-to-close, from daily closes). Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34. The specific nature of the material event was not disclosed in available sources, but the filing coincided with below-average trading volume (0.46x expected), suggesting limited institutional participation in the selloff. Source: FMP price data; BestStocks detection.

Updated
Prior close
$31.33
Nov 17, 2026 close
$29.84
Change (close-to-close)
−$1.49
−4.76%
As first detected · Nov 17, 2026, 2:32 PM ET

Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34. The specific nature of the material event was not disclosed in available sources, but the filing coincided with below-average trading volume (0.46x expected), suggesting limited institutional participation in the selloff.

What to watch next: Review the full 8-K filing details once public disclosure is finalized; monitor for earnings on 2027-02-09 (consensus EPS estimate: −$1.08) for forward-looking guidance.

Source: FMP price data; BestStocks detection · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved OSCR

  1. −2.8%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  2. −4.1%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
  3. +4.1%After the company integrated HealthEx's medical records connectivity into its app for new members from day one.
  4. +4.9%After the company raised its full-year operating earnings outlook for the third time following a profitable Q3, citing membership growth and a $250M risk-adjustment benefit.
  5. −7.6%A material event filing (8-K) was also submitted today.
  6. −5.7%Despite reporting Q3 2026 EPS of $0.49, which beat the consensus loss estimate of $0.14 by $0.60 per share.
  7. +4.5%Ahead of its earnings announcement scheduled for 2026-11-05.
  8. −2.8%We checked news, earnings announcements, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
  9. −7.0%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  10. +3.4%After announcing its expansion into South Carolina, bringing its footprint to 713 counties across 21 states by 2027.
  11. −4.7%OSCR moved -4.82% from its $33.51 open to a $31.89 close on 2026-10-16.
  12. +4.8%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  13. +3.5%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
  14. −3.0%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
  15. +3.6%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.

Oscar Health, Inc. (OSCR) shares fell 4.8% to $29.84 as of November 17, 2026, a moderate decline from the prior close of $31.33. BestStocks flagged the session as a major change for OSCR. Below, we break down what changed for OSCR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

OSCR fell 4.8% to $29.84

Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34. The specific nature of the material event was not disclosed in available sources, but the filing coincided with below-average trading volume (0.46x expected), suggesting limited institutional participation in the selloff. Review the full 8-K filing details once public disclosure is finalized; monitor for earnings on 2027-02-09 (consensus EPS estimate: −$1.08) for forward-looking guidance.

This summary describes the catalyst and move as first detected on Nov 17, 2026, 2:32 PM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
RiskLow confidence
Rel. volume
0.8×
Below Avg
Vs peers
—
No comparable peers
Market cap
$7.7B
New York Stock Exchange
Analyst target
$37
+25.4% vs price
Price chart
Nov 17
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Oscar Health, Inc. investors

For Oscar Health, Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Earnings beat — stock sold off (sell-the-news reaction); Oscar Health beat Q3 2026 earnings and revenue estimates and raised its full-year 2026 outlook, per Business Wire and Zacks. Weighing against that: Negative session, down 4.8%; Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34. Wall Street's consensus price target sits at $37.43, implying +25.4% upside from $29.84. BestStocks rates the overall signal quality low (55/100). With earnings roughly 84 days out, the next report is the most likely near-term test of the move.

OSCR price reaction

OSCR last traded at $29.84, down $1.49 (-4.76%) from the previous close of $31.33. The session traded on 0.8× average volume (below avg), so participation was unremarkable.

Bullish and bearish analyst opinions on Oscar Health, Inc. (OSCR)

Latest catalysta bearish counterpoint
The latest catalyst — a flagged risk event — a bearish counterpoint that challenges the prevailing bullish analyst view.

The consensus analyst price target on Oscar Health, Inc. (OSCR) is $37.43, 25.4% above the recent $29.84. Over the past 90 days analysts logged 0 upgrades, 7 maintains, and 0 downgrades. Here is how the bullish and bearish cases on OSCR line up.

The bullish case

  • Wall Street's consensus price target of $37.43 implies +25.4% upside from $29.84.
  • The Street's most bullish target is $49.00 (+64.2%).
  • Earnings beat — stock sold off (sell-the-news reaction).
  • Oscar Health beat Q3 2026 earnings and revenue estimates and raised its full-year 2026 outlook, per Business Wire and Zacks.
  • Oscar Health, Inc. (OSCR) moved +5.28% from $26.50 to $27.90 on August 7, 2026.

The bearish case

  • The most bearish analyst target is $20.00 (-33.0%).
  • Negative session, down 4.8%.
  • Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34.
  • Oscar Health reported Q3 earnings today with strong outlook and margin gains (Zacks), yet the stock fell 6.37% to $31.07.
Bull vs bear balanceBearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 17, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $37+25.4%
= 7 maintains
Piper Sandler maintained Overweight · 2026-11-06
SEC filings watch
No recent filings
Peer context
OSCR-4.8%

Previous notable changes for OSCR

News2026-11-16
Oscar Health appointed three new board members: Tomer Cohen, Eric Larsen, and Rajat Taneja, effective November 13, 2026.
News2026-11-10
Oscar Insurance integrated HealthEx's medical records connectivity into its app for new members from day one.
Risk2026-11-06via zacks.com ↗
Oscar Health reported Q3 earnings today with strong outlook and margin gains (Zacks), yet the stock fell 6.37% to $31.07. A material event filing (8-K) was also submitted today. Volume of 1.78M shares ran 1.45x normal for this time of session, indicating active intraday selling despite positive earnings commentary.
Material / Earnings2026-11-05
Oscar Health, Inc. (OSCR) reported EPS of $0.49 vs. a consensus estimate of -$0.14, beating estimates by 440.7% on 2026-11-05.
Upcoming catalysts & outlook
Next earnings
2027-02-09 (est.)
in 84 days
Thesis shift
Bearish Shift
bearish signal
Risk level
High
from change events

Frequently asked questions about OSCR

Why did Oscar Health, Inc. (OSCR) stock move?

Oscar Health, Inc. (OSCR) fell 4.8% on November 17, 2026, closing at $29.84 versus $31.33 the prior session (close-to-close, from daily closes). Oscar Health filed a material event 8-K today, triggering a 3.18% decline to $30.34. The specific nature of the material event was not disclosed in available sources, but the filing coincided with below-average trading volume (0.46x expected), suggesting limited institutional participation in the selloff. Source: FMP price data; BestStocks detection.

How much did OSCR stock fall?

OSCR lost 4.76% ($1.49) versus the prior close of $31.33, last trading at $29.84 on 0.8× average volume.

When is Oscar Health, Inc.'s next earnings date?

OSCR's next earnings report is estimated for 2027-02-09 — about 84 days away.

What is the analyst price target for OSCR?

The consensus analyst price target for OSCR is $37.43, about 25.4% above the current $29.84. Over the past 90 days, analysts recorded 0 upgrades, 7 maintains, and 0 downgrades.

How BestStocks tracks OSCR

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared OSCR-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for OSCR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 17, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsFMP earnings & estimatesSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.